NYSE - Delayed Quote • USD
CONMED Corporation (CNMD)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:25 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 8 |
Avg. Estimate | 0.74 | 0.97 | 4.33 | 5.62 |
Low Estimate | 0.73 | 0.94 | 4.3 | 5.37 |
High Estimate | 0.74 | 1.11 | 4.36 | 5.8 |
Year Ago EPS | 0.66 | 0.83 | 3.45 | 4.33 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 8 |
Avg. Estimate | 306.78M | 341.9M | 1.35B | 1.52B |
Low Estimate | 304.8M | 338.38M | 1.34B | 1.44B |
High Estimate | 308M | 350.65M | 1.36B | 1.9B |
Year Ago Sales | -- | 306.09M | 1.24B | 1.35B |
Sales Growth (year/est) | -- | 11.70% | 8.40% | 12.70% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.6 | 0.79 | 0.83 | 1.11 |
EPS Actual | 0.66 | 0.83 | 0.9 | 1.06 |
Difference | 0.06 | 0.04 | 0.07 | -0.05 |
Surprise % | 10.00% | 5.10% | 8.40% | -4.50% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.74 | 0.97 | 4.33 | 5.62 |
7 Days Ago | 0.74 | 0.97 | 4.33 | 5.62 |
30 Days Ago | 0.74 | 0.97 | 4.33 | 5.62 |
60 Days Ago | 0.74 | 0.99 | 4.33 | 5.62 |
90 Days Ago | 0.9 | 1.08 | 4.4 | 5.82 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | 1 |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CNMD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 12.10% | -- | -- | 1.50% |
Next Qtr. | 16.90% | -- | -- | 11.40% |
Current Year | 25.50% | -- | -- | 5.20% |
Next Year | 29.80% | -- | -- | 13.40% |
Next 5 Years (per annum) | 25.40% | -- | -- | 11.09% |
Past 5 Years (per annum) | 4.97% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Piper Sandler: Overweight to Overweight | 2/1/2024 |
Maintains | JP Morgan: Overweight to Overweight | 2/1/2024 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/1/2024 |
Maintains | Needham: Buy to Buy | 2/1/2024 |
Maintains | Piper Sandler: Overweight to Overweight | 10/27/2023 |
Maintains | Stifel: Buy to Buy | 10/26/2023 |
Related Tickers
IART Integra LifeSciences Holdings Corporation
29.38
0.00%
IRTC iRhythm Technologies, Inc.
116.43
+0.08%
PEN Penumbra, Inc.
206.15
+0.22%
KIDS OrthoPediatrics Corp.
31.20
+1.86%
NVRO Nevro Corp.
12.51
-2.19%
OFIX Orthofix Medical Inc.
13.56
+2.57%
STE STERIS plc
202.80
-1.55%
ATEC Alphatec Holdings, Inc.
12.74
-1.47%
SNN Smith & Nephew plc
24.57
-0.93%
QDEL QuidelOrtho Corporation
40.82
+1.04%